Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

More articles from Clinical Studies

  • You have access
    The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, ITARU HASHIMOTO, KAZUKI KANO, KENTARO HARA, HARUHIKO CHO, KENKI SEGAMI, DAISUKE MACHIDA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research May 2022, 42 (5) 2711-2717; DOI: https://doi.org/10.21873/anticanres.15749
  • You have access
    Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
    SUGURU SHIROTAKE, YU MIYAMA, YASUTAKA BABA, HIROYUKI TAJIMA, YOSHITAKA OKADA, KEN NAKAZAWA, YOKO USAMI, MASANORI YASUDA, DAISUKE IGARASHI, GO KANEKO, KENT KANAO, MASAFUMI OYAMA and KOSHIRO NISHIMOTO
    Anticancer Research May 2022, 42 (5) 2727-2735; DOI: https://doi.org/10.21873/anticanres.15751
  • You have access
    Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study
    KOICHI OKAMOTO, ITASU NINOMIYA, HIROTO SAITO, MARI SHIMADA, TAKAHISA YAMAGUCHI, SHIRO TERAI, HIDEKI MORIYAMA, JUN KINOSHITA, KEISHI NAKAMURA and NORIYUKI INAKI
    Anticancer Research May 2022, 42 (5) 2783-2790; DOI: https://doi.org/10.21873/anticanres.15758
  • You have access
    Prognostic Value of the Regional Lymph Node Station in Pancreatic Neuroendocrine Tumor
    KOSEI TAKAGI, YUZO UMEDA, RYUICHI YOSHIDA, KAZUHIRO YOSHIDA, TOMOKAZU FUJI, KENJIRO KUMANO, KAZUYA YASUI, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA
    Anticancer Research May 2022, 42 (5) 2797-2801; DOI: https://doi.org/10.21873/anticanres.15760
  • Open Access
    Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes
    SIDDHARTH KUNTE, JONATHAN SHARETT, WEI WEI, CHRISTIAN NASR, BRANDON PRENDES, ERIC LAMARRE, JAMIE KU, ROBERT R. LORENZ, JOSEPH SCHARPF, BRIAN B. BURKEY, AKEESHA SHAH, NIKHIL JOSHI and JESSICA L. GEIGER
    Anticancer Research May 2022, 42 (5) 2531-2539; DOI: https://doi.org/10.21873/anticanres.15731
  • Open Access
    Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial
    KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA and KENSEI YAMAGUCHI
    Anticancer Research May 2022, 42 (5) 2683-2687; DOI: https://doi.org/10.21873/anticanres.15746
  • You have access
    Impact of Histological Features on Adjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Carcinoma
    TAKAAKI FURUKAWA, MANABU TAKAMATSU, YOSUKE INOUE, TAKESHI OKAMOTO, TAKAFUMI MIE, YUTO YAMADA, TSUYOSHI TAKEDA, AKIYOSHI KASUGA, MASATO MATSUYAMA, TAKASHI SASAKI, MASATO OZAKA, ATSUSHI OBA, HIROMICHI ITO, YOSHIHIRO ONO, TAKAFUMI SATO, YU TAKAHASHI, AKIO SAIURA and NAOKI SASAHIRA
    Anticancer Research May 2022, 42 (5) 2645-2655; DOI: https://doi.org/10.21873/anticanres.15742
  • You have access
    Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study
    MIHO TAKEMURA, KENJI IKEMURA, TETSUHIRO YOSHINAMI, YUJI TOYOZUMI, TAKUYA SHINTANI, MIKIKO UEDA, KENZO SHIMAZU and MASAHIRO OKUDA
    Anticancer Research May 2022, 42 (5) 2591-2598; DOI: https://doi.org/10.21873/anticanres.15737
  • Open Access
    A Higher Mean Heart Radiation Dose Induces Higher Frequency of Multiple Cardiac Changes
    SUVI SIRKKU TUOHINEN, HANNA AULA, TANJA SKYTTÄ, HEINI HUHTALA, KONSTA KESKI-PUKKILA, KJELL NIKUS, VESA VIRTANEN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and PEKKA RAATIKAINEN
    Anticancer Research May 2022, 42 (5) 2519-2529; DOI: https://doi.org/10.21873/anticanres.15730
  • You have access
    Chemotherapy-induced Reversion of Mutant RAS to Wild-type RAS in Metastatic Colorectal Cancer
    SUMITO SATO, YO MIKAYAMA, MANABU SHIOZAWA, SUGURU NUKADA, KENTA IGUCHI, HIRONAO OKAMOTO, TAKASHI KOHMURA, KEISUKE KAZAMA, KUNIYA TANAKA, TAKASHI OSHIMA and YASUSHI RINO
    Anticancer Research May 2022, 42 (5) 2625-2635; DOI: https://doi.org/10.21873/anticanres.15740

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 674
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire